Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractGenetic aberrations in tumors are predictive for chemosensitivity and survival. A test is needed that allows simultaneous detection of multiple changes and that is widely applicable in a routine diagnostic setting. Multiplex ligation-dependent probe amplification (MLPA) allows detection of DNA copy number changes of up to 45 loci in one relatively simple, semiquantitative polymerase chain reaction-based assay. To assess the applicability of MLPA, we performed MLPA analysis to detect relevant genetic markers in a spectrum of 88 gliomas. The vast majority of these tumors (n = 79) were previously characterized by comparative genomic hybridization. With MLPA kit P088 (78 cases), complete and partial loss of 1p and 19q were reliably identified, even in samples containing only 50% tumor DNA. Distinct 1p deletions exist with different clinically prognostic consequences, and in contrast to the commonly used diagnostic strategies (loss of heterozygosity or fluorescent in situ hybridization 1p36), P088 allows detection of such distinct 1p losses. Combining P088 with P105 will further increase the accurate prediction of clinical behavior because this kit identified markers (EGFR, PTEN, and CDKN2A) of high-grade malignancy in 41 cases analyzed. We conclude that MLPA is a reliable diagnostic tool for simultaneous identification of different region-specific genetic aberrations of tumors.
CitationJ. Mol. Diagn. 2006, 8 (4):433-443
DescriptionBiomarkers of exposure & effect: validation Biomarker: Exposure/effect represented: Analytical technicque: Sensitivity (LOD): Specificity: Accuracy: Repeatability (intralaboratory repeatability): Reproducibility (intralaboratory repeatability): Stability in stored sample: High-throughput automation: Notes:
SponsorsSupported by the Dutch Cancer Society (Konigin Wihelmina Fonds: Katholic University Nijmegen 2004-3143) and the Pauline van Everdingen Foundation.
- [Identification of genetic alterations by multiple ligation-dependent probe amplification (MLPA) analysis in oligodendrogliomas].
- Authors: Franco-Hernández C, Martínez-Glez V, Torres-Martín M, de Campos JM, Isla A, Vaquero J, Casartelli C, Rey JA
- Issue date: 2009 Apr
- Allelic status of 1p and 19q in oligodendrogliomas and glioblastomas: multiplex ligation-dependent probe amplification versus loss of heterozygosity.
- Authors: Franco-Hernández C, Martínez-Glez V, de Campos JM, Isla A, Vaquero J, Gutiérrez M, Casartelli C, Rey JA
- Issue date: 2009 Apr 15
- Multiplex ligation-dependent probe amplification for the detection of 1p and 19q chromosomal loss in oligodendroglial tumors.
- Authors: Natté R, van Eijk R, Eilers P, Cleton-Jansen AM, Oosting J, Kouwenhove M, Kros JM, van Duinen S
- Issue date: 2005 Jul
- Genome profiling of melanocytic tumors using multiplex ligation-dependent probe amplification (MLPA): Its usefulness as an adjunctive diagnostic tool for melanocytic tumors.
- Authors: Takata M, Suzuki T, Ansai S, Kimura T, Shirasaki F, Hatta N, Saida T
- Issue date: 2005 Oct
- Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
- Authors: Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M
- Issue date: 2005 Feb 1